Todd C. Davis - Jul 2, 2025 Form 4 Insider Report for Pelthos Therapeutics Inc. (PTHS)

Role
Director
Signature
/s/ Todd C. Davis
Stock symbol
PTHS
Transactions as of
Jul 2, 2025
Transactions value $
$0
Form type
4
Date filed
7/7/2025, 09:43 PM
Previous filing
Jul 3, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Davis Todd C Director C/O PELTHOS THERAPEUTICS INC., 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM /s/ Todd C. Davis 2025-07-07 0001392029

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTHS Restricted Stock Units Award +19.1K +106.98% 37K Jul 2, 2025 Common Stock 19.1K $13.50 Direct F1, F3
transaction PTHS Stock Option Award +58.2K 58.2K Jul 2, 2025 Common Stock 58.2K $13.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 19,108 shares of common stock at an exercise price of $13.50 per share, which shall vest on a quarterly basis over a period of three (3) years.
F2 On July 2, 2025, the Reporting Person was granted stock options to purchase 58,230 shares of common stock at an exercise price of $13.50 per share, which shall vest on a quarterly basis over a period of three (3) years.
F3 The numbers reported herein have been adjusted to reflect the 1-for-10 reverse stock split effected by the Issuer on July 1, 2025.